We are live on !
Find out more
MA
McBroom & Associates Portfolio holdings
AUM
$165M
Turnover
15.79%
1-Year Est. Return
20.64%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
+20.64%
3 Year Est. Return
+148.07%
5 Year Est. Return
+212.74%
10 Year Est. Return
–
AUM
$165M
AUM Growth
-$33.4M
(-17%)
Cap. Flow
-$29.8M
Cap. Flow % of AUM
Cap. Flow %
-18.01%
Top 10 Holdings %
Top 10 Hldgs %
61.75%
Holding
38
New
1
Increased
5
Reduced
23
Closed
5
Avg Time Held
3.2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.81M |
| 2 |
Axon Enterprise
AXON
|
+$1.54M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$634K |
| 4 |
Vertiv
VRT
|
+$354K |
| 5 |
iShares MSCI Intl Value Factor ETF
IVLU
|
+$283K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dick's Sporting Goods
DKS
|
+$8.4M |
| 2 |
Intuitive Surgical
ISRG
|
+$4.82M |
| 3 |
Lam Research
LRCX
|
+$4.56M |
| 4 |
NVIDIA
NVDA
|
+$4.36M |
| 5 |
TJX Companies
TJX
|
+$2.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.38% |
| 2 | Consumer Discretionary | 15.12% |
| 3 | Miscellaneous | 13.85% |
| 4 | Healthcare | 9.34% |
| 5 | Consumer Staples | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$4.94T
| $15.8M | 9.57% |
69,316
-20,317
| -23% | -$4.36M |
2021 Q4
19 quarters
|
|
|
2
Lam Research
LRCX
$299B
| $13.4M | 8.1% |
40,801
-14,602
| -26% | -$4.56M |
2024 Q4
7 quarters
|
|
3
Palantir
PLTR
$442B
| $11.8M | 7.12% |
62,974
-7,683
| -11% | -$1.22M |
2024 Q3
8 quarters
|
|
4
Apple
AAPL
$5.03T
| $10.3M | 6.2% |
30,812
-4,663
| -13% | -$1.5M |
2021 Q4
19 quarters
|
|
5
JPMorgan Chase
JPM
$895B
| $9.38M | 5.67% |
28,339
-3,512
| -11% | -$1.23M |
2021 Q4
19 quarters
|
|
6
Microsoft
MSFT
$3.88T
| $8.92M | 5.39% |
17,394
-132
| -0.8% | -$61K |
2021 Q4
19 quarters
|
|
7
Johnson & Johnson
JNJ
$658B
| $8.71M | 5.26% |
32,884
-4,002
| -11% | -$1.06M |
2021 Q4
19 quarters
|
|
8
Costco
COST
$449B
| $8.31M | 5.02% |
9,123
-1,330
| -13% | -$1.24M |
2021 Q4
19 quarters
|
|
9
O'Reilly Automotive
ORLY
$70.9B
| $8.24M | 4.98% |
96,505
-14,721
| -13% | -$1.3M |
2021 Q4
19 quarters
|
|
10
Tesla
TSLA
$1.58T
| $7.36M | 4.45% |
20,752
-1,522
| -7% | -$545K |
2021 Q4
19 quarters
|
|
11
SPDR Gold Trust
GLD
$130B
| $6.28M | 3.79% |
16,480
-1,893
| -10% | -$740K |
2021 Q4
19 quarters
|
|
|
12
iShares MSCI Intl Value Factor ETF
IVLU
$4.49B
| $6.16M | 3.72% |
143,612
+6,497
| +5% | +$283K |
2025 Q4
3 quarters
|
|
|
13
TJX Companies
TJX
$154B
| $5.27M | 3.18% |
39,828
-16,407
| -29% | -$2.37M |
2022 Q4
15 quarters
|
|
|
14
Vertiv
VRT
$89.5B
| $4.97M | 3% |
20,593
+1,298
| +7% | +$354K |
2026 Q2
1 quarter
|
|
15
Vistra
VST
$46.4B
| $4.95M | 2.99% |
35,787
-5,089
| -12% | -$749K |
2024 Q4
7 quarters
|
|
|
16
Eli Lilly
LLY
$1.26T
| $4.72M | 2.85% |
+4,078
| New | +$4.81M |
2026 Q3
0 quarters
|
|
|
17
Axon Enterprise
AXON
$34.8B
| $4.45M | 2.69% |
10,537
+2,854
| +37% | +$1.54M |
2025 Q1
6 quarters
|
|
18
Home Depot
HD
$328B
| $3.19M | 1.93% |
11,222
-2,296
| -17% | -$754K |
2021 Q4
19 quarters
|
|
19
Schwab U.S Small- Cap ETF
SCHA
$22B
| $3.13M | 1.89% |
95,772
-1,306
| -1% | -$44.7K |
2026 Q2
1 quarter
|
|
|
20
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $3.04M | 1.84% |
3,986
+834
| +26% | +$634K |
2021 Q4
19 quarters
|
|
21
Sprouts Farmers Market
SFM
$4.58B
| $2.92M | 1.77% |
44,062
-6,711
| -13% | -$524K |
2025 Q1
6 quarters
|
|
22
McKesson
MCK
$116B
| $2.04M | 1.23% |
2,385
-26
| -1% | -$22.4K |
2022 Q3
16 quarters
|
|
23
Berkshire Hathaway Class B
BRK.B
$1.16T
| $1.9M | 1.15% |
3,822
| – | – |
2022 Q3
16 quarters
|
|
24
iShares Short-Term National Muni Bond ETF
SUB
$13.1B
| $1.61M | 0.97% |
15,375
-4,810
| -24% | -$509K |
2021 Q4
19 quarters
|
|
25
Philip Morris
PM
$325B
| $1.42M | 0.86% |
7,447
-288
| -4% | -$54.4K |
2024 Q1
10 quarters
|
|
Similar funds
GC
McBroom & Associates's Q3 2026 Portfolio in Review
As of Q3 2026, McBroom & Associates held 38 positions worth $165M, down 17% from $199M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
McBroom & Associates withdrew a net $29.8M in Q3 2026, closing 5 positions and reducing 23 holdings. Its most notable exit was Dick's Sporting Goods, an estimated $8.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
Against the trend, McBroom & Associates opened a new position in Eli Lilly worth $4.72M.
- McBroom & Associates's largest Q3 2026 buy was Eli Lilly: 4,078 shares worth $4.72M.
- McBroom & Associates added most to Axon Enterprise in Q3 2026, an estimated $1.54M increase.
- McBroom & Associates's biggest Q3 2026 reduction was Lam Research, cutting an estimated $4.56M.
- McBroom & Associates fully exited Dick's Sporting Goods in Q3 2026, selling an estimated $8.4M.
- McBroom & Associates's ten largest holdings make up 62% of its $165M portfolio in Q3 2026.
- McBroom & Associates opened 1 new position and closed 5 in Q3 2026.
- McBroom & Associates's portfolio value fell 17% quarter-over-quarter to $165M.
Based on McBroom & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.